Exercise intolerance in chronic heart failure: mechanisms and therapies. Part II. - Wikidata - awgldk - TriplyDB

Exercise intolerance in chronic heart failure: mechanisms and therapies. Part II.

Exercise intolerance in chronic heart failure: mechanisms and therapies. Part II.

http://www.wikidata.org/entity/Q37827023

about

Effect of aerobic training on heart rate recovery in patients with established heart disease; a systematic review.Muscle oxygen transport and utilization in heart failure: implications for exercise (in)tolerance.Pulmonary congestion at rest and abnormal ventilation during exercise in chronic systolic heart failure.Neuromuscular electrical stimulation for muscle weakness in adults with advanced disease.Exercise training in chronic heart failure: improving skeletal muscle O2 transport and utilization.Research on cachexia, sarcopenia and skeletal muscle in cardiology.Effects of exercise on cardiovascular performance in the elderly.Skeletal muscle microvascular oxygenation dynamics in heart failure: exercise training and nitric oxide-mediated function.Cardiopulmonary exercise testing in systolic heart failure in 2014: the evolving prognostic role: a position paper from the committee on exercise physiology and training of the heart failure association of the ESC.Vascular KATP channels mitigate severe muscle O2 delivery-utilization mismatch during contractions in chronic heart failure rats.Differential expression of circulating microRNAs in blood and haematoma samples from patients with intracerebral haemorrhage.MicroRNAs in Vascular Biology Heart failure special edition.The impact of exercise on physical function, cardiovascular outcomes and quality of life in chronic kidney disease patients: a systematic review.Impact of exercise training on adverse event risk and quality of life in patients with heart failure.Age-related impact of depressive symptoms on functional capacity measured with 6-minute walking test in coronary artery disease.ACE-Inhibition Benefit on Lung Function in Heart Failure is Modulated by ACE Insertion/Deletion Polymorphism.The effects of dietary fish oil on exercising skeletal muscle vascular and metabolic control in chronic heart failure rats.Exercise performance of chronic heart failure patients in the early period of support by an axial-flow left ventricular assist device as destination therapy.

P2860

Q35075621-4C8D4DA2-D0DA-4B74-8A8F-95A1C725D81C Q35850050-7590BEE2-A359-42DB-8B48-A7165EFF8B36 Q36141321-6BAD7C29-3B0D-4CE6-AC2F-F45869421E00 Q36164912-182A6624-5662-4E22-80A7-C09D2C72CD2D Q36339431-52DA2A21-BC38-4BEE-887E-1BE4A804FDA7 Q36421043-0F255FC4-E9A4-4F72-9771-99DAB4E2924B Q37594289-80D4E7B7-1739-4D2C-8BCD-E8D51AE06BC6 Q37629263-DE26DC17-5441-4131-B2D4-70D6E3233E06 Q38245121-5747CF61-115D-42A0-B612-886312D90A54 Q39001287-0ACB97BC-7BBF-47D3-B90C-D738E515313B Q41837797-F05ADCBA-6505-4B71-9B97-47CBF41C3FF3 Q42121996-68D85F85-23DF-49DF-98CA-880ADCEF6447 Q42325575-57842EA0-6713-4951-BA78-531C647082B0 Q47652917-309C3BEE-418C-4FF8-A6DB-1018E4E3BB46 Q48394412-9E2750F6-1C10-4604-ABF1-4D3051070ACF Q48459434-24A9359C-C8EF-475B-8B81-6488317D3D30 Q51549504-C6843AF8-AE8B-4E66-B9D9-7EBB4489F1DD Q54301411-AF26A6DA-EAB0-41F4-95A8-8C7EA48AD1FC Q54777166-2CEFF637-CAD5-49B2-8652-1D6DAC7AF193

P2860

Exercise intolerance in chronic heart failure: mechanisms and therapies. Part II.

http://www.wikidata.org/entity/Q37827023

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Exercise intolerance in chronic heart failure: mechanisms and therapies. Part II.

@en

Exercise intolerance in chronic heart failure: mechanisms and therapies. Part II.

@nl

type

label

Exercise intolerance in chronic heart failure: mechanisms and therapies. Part II.

@en

Exercise intolerance in chronic heart failure: mechanisms and therapies. Part II.

@nl

prefLabel

Exercise intolerance in chronic heart failure: mechanisms and therapies. Part II.

@en

Exercise intolerance in chronic heart failure: mechanisms and therapies. Part II.

@nl

P1433

Q37827023-7B7D830D-4944-4A3D-A911-468B45B32C7A

P1476

Q37827023-977266AE-1CEC-4270-9BFB-8980A74712AA

P2093

Q37827023-376A9995-EA55-4F34-98B2-C01C8AE34836

Q37827023-4979C51D-3B97-4A8E-9F11-5400CEADDCD4

Q37827023-5B7DA157-B064-4FC0-9799-FEEA73A62971

Q37827023-5F608DEE-5D40-4A67-8C2C-D4A90EC34396

Q37827023-9784105B-8792-40CB-89E5-80BD2A300C83

Q37827023-B3D14E98-EB53-43A5-A082-21456AB5C755

Q37827023-C83A5F52-C0E3-4252-8396-07DA437C4045

Q37827023-FA015D0A-70E9-48F9-B178-40A8A662AB8D

Q37827023-FE8DE870-3DBB-44D3-97B7-EB9FF3204860

P2860

Q37827023-02092CEF-931E-4557-A0A6-D417BB58A524

Q37827023-04D0C9CA-789C-4804-947A-625DE1D4ACDE

Q37827023-0709E18A-ECB1-4572-8C07-21BA38CA5F4D

Q37827023-1ED50E81-3688-42E7-98FE-9927109FC756

Q37827023-20C34794-2D1D-4C65-B610-622DA56A669A

Q37827023-2CB9C085-6DA7-4EE3-9C8B-4D58A15C88E0

Q37827023-386B7372-DB48-4E8F-BC80-6E4F89DABD3C

Q37827023-60687EBD-2BBF-4E2B-859A-58DE63B314E8

Q37827023-61A2DC0D-25BA-4409-AF43-DF1EE2552729

Q37827023-6517FF1B-1EBC-4351-8625-828429139857

P304

Q37827023-74BB61DE-1718-4DF6-A82F-5CF9AFE829CD

P31

Q37827023-403303ba-1656-42dd-8974-8d6353113f5c

Q37827023-5492AC1A-2B27-4AE9-82E3-C393C8FDAF83

P356

Q37827023-71FCE2CA-BD57-43D1-B4C5-E39F29010C86

P433

Q37827023-F2D1A27E-8E38-4999-B315-27FB75ED055E

P478

Q37827023-A03D88BE-A6BC-4386-9193-0F4E2B3EE719

P50

Q37827023-05570D5F-B0B9-44BC-8302-42716A5F6559

Q37827023-4143E202-FD95-42F9-AED7-7C8ACDF676AB

Q37827023-6E38D1B8-ADB2-447F-80FB-F8E9C916C04F

Q37827023-C93E6039-8D22-4F98-BA2D-62EDFD7AB7BB

Q37827023-E2ECD019-B1A0-4274-A54A-7130E6DADA46

P577

Q37827023-3B078C50-404F-411D-83B9-75E7AF1580CE

P698

Q37827023-909FB626-5279-421F-915D-96492CC7DF45

P921

Q37827023-9DBF6EB7-B4A8-4A07-A88B-87229C516B8D

P356

HJR.0B013E32833F3AA5

P1433

European Journal of Cardiovascular Prevention and Rehabilitation

P1476

Exercise intolerance in chronic heart failure: mechanisms and therapies. Part II.

@en

P2093

Carlo Vigorito

http://www.w3.org/2001/XMLSchema#string

Giorgio Vescovo

http://www.w3.org/2001/XMLSchema#string

Luciano Dalla Libera

http://www.w3.org/2001/XMLSchema#string

Mariantonietta Cicoira

http://www.w3.org/2001/XMLSchema#string

Massimo F Piepoli

http://www.w3.org/2001/XMLSchema#string

Michele Emdin

http://www.w3.org/2001/XMLSchema#string

Piergiuseppe Agostoni

http://www.w3.org/2001/XMLSchema#string

Ugo Corrà

http://www.w3.org/2001/XMLSchema#string

Working Group ‘Exercise Physio ...... Italian Society of Cardiology

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial

Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study.

Wasting as independent risk factor for mortality in chronic heart failure.

Exercise performance following cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay.

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the

Exercise and heart failure: A statement from the American Heart Association Committee on exercise, rehabilitation, and prevention.

Cardiac resynchronization by pacing: an electrical treatment of heart failure.

Alveolar epithelial beta 2-adrenergic receptors: their role in regulation of alveolar active sodium transport.

Cardiac resynchronization therapy in clinical practice: need for electrical, mechanical, clinical and logistic synchronization.

Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review.

P304

643-648

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/HJR.0B013E32833F3AA5

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

Giuseppe Boriani

Claudio Passino

Giovanni Quinto Villani

P577

2010-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21217245

http://www.w3.org/2001/XMLSchema#string

P921